Sera Prognostics Incorporated is a women's health diagnostic company. It offers biomarker tests for improving pregnancy outcomes by testing for preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. PreTRM, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies, was one of the company's first successes. Sera Prognostics was incorporated in 2008 and is headquartered in Salt Lake City, UT.
What is Sera Prognostics's quote symbol?
What is the 52 week high and low for Sera Prognostics (NASDAQ: SERA)?
How much is Sera Prognostics stock worth today?
How much is Sera Prognostics's stock price per share?
What is Sera Prognostics's Market Cap?